Table: begin end state 1 20 cytoplasmic 21 42 transmembrane 43 47 non-cytoplasmic 48 67 transmembrane 68 87 cytoplasmic 88 111 transmembrane 112 121 non-cytoplasmic 122 144 transmembrane 145 155 cytoplasmic 156 180 transmembrane 181 199 non-cytoplasmic 200 223 transmembrane 224 241 cytoplasmic 242 264 transmembrane 265 282 non-cytoplasmic 283 304 transmembrane 305 331 cytoplasmic 332 354 transmembrane 355 360 non-cytoplasmic 361 382 transmembrane 383 401 cytoplasmic 402 423 transmembrane 424 428 non-cytoplasmic 429 446 transmembrane 447 470 cytoplasmic
Input: >WP_058929813.1 NCBI__GCF_001484605.1:WP_058929813.1 MEQQTMTSGRALGAALKPRQLTMMGLGSAIGAGLFIGSGAGIQAAGPAVLISYLVAGTLI ILVMWALGEMAAANPDSGAFSVYTAKAYGPVAGATVGWLWWLQLVVVIAAEALGAAGLLS TIFPALPVWLMAFVFIVVLTAVNLTSVKNFGEFEFWFALLKVAAIVGFLLVGAALLFGWL PGVQSPGLANFTGDGFAPDGFAGIATALFVVAFAFGGTEIVSVAAAETAEPARSVRTAVR TVLWRILVFYIGAIFVIAAVVPVGSAGLKSPFAAVLEAAGMPGAATAITLVAVAALLSAL NANLYGASRMAYSLADRGEAPRLLASVSKARVPVVAVLASVAFGVVTVVLELAFPEKVLP VLLNIVGSTCLLVWTSALLAQLALRLRANREGTELPLRMPGFPWLTCFGLLILAAIFTVG FIGEDSRPQLLSTFALVALLAVANWLHHRSGKVAGRVEAAEGDKQPVLID
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server